Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaoyan Shen
Observed names:
X. Shen,
Xiao-yan Shen
Institution:
Peking University People's Hospital
Observed institutions:
Northeast Normal University,
Shandong Normal University,
Nanjing Drum Tower Hospital,
Peking University People's Hospital,
3D Medicines, Inc. (China),
Nanjing Medical University,
Nanjing University
show all 7
ORCID:
0000-0002-7873-3920
Observed ORCID:
0000-0002-7873-3920
OpenAlex ID:
A5100613307
Transcriptomic profiling revealed an important role of cell wall remodeling and ethylene signaling pathway during salt acclimation in Arabidopsis
2014
·
Xiaoyan Shen
, Zenglan Wang
, et al.
·
Plant Molecular Biology
·
167
The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC
2017
·
Yang Yang
, Xiaoyan Shen
, et al.
·
Oncotarget
·
31
Detection of EGFR and BRAF mutations by competitive allele-specific TaqMan polymerase chain reaction in lung adenocarcinoma
2017
·
Yang Yang
, Yi Meng
, et al.
·
Oncology Letters
·
15
PDF
Phytoestrogens inhibiting androgen receptor signal and prostate cancer cell proliferation
2013
·
Jing Wu
, Shu Liu
, et al.
·
Chemical Research in Chinese Universities
·
11
Tubeimoside-1 upregulates p21 expression and induces apoptosis and G2/M phase cell cycle arrest in human bladder cancer T24 cells
2014
·
Azhar Rasul
, Xiaoyan Shen
, et al.
·
Bangladesh Journal of Pharmacology
·
6
PDF
Sensitivity of Platinum‐Based Chemotherapy and Efficacy of Arsenic Trioxide‐Based Non‐Platinum Chemotherapy Following the Progression of PARPi Maintenance Therapy: A Real‐World Study
2025
·
Rui Gou
, Qi Xie
, et al.
·
Cancer Medicine
·
2
PDF
A novel device to capture circulating tumor cells: Quantification and molecular analysis in lung cancer patients
2020
·
Yuxin Cheng
, Jie Shen
, et al.
·
Journal of Biomaterials Applications
·
2
Detection and monitoring of driver mutations by next‐generation sequencing in squamous cell lung cancer patient and possible predictive biomarker of third generation EGFR‐tyrosine kinase inhibitors
2017
·
Xiaoyan Shen
, Jie Shen
, et al.
·
Thoracic Cancer
·
1
PDF
1250P Differences of immune microenvironment among NSCLC patients with various KRAS mutation types
2021
·
K. Wang
, H. Zhang
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
9
Citation count:
245
H-index:
5
I10-index:
4
Year
Topic
Type